Integumentary – 2 New Codes

Musculoskeletal – 42 New Codes

• Excision of Soft Tissue Tumors
• Radical Resection of Soft Tissue Tumors
  • Codes 21011 – 28047

Respiratory– 14 New Codes

• Bronchoscopy – 2 New Codes (31626 & 31627)
• Instillation(s), via Chest Tube/Catheter, Agent for Fibrinolysis (32561 & 32562)
• Replacement of Ventricular Assist Device (33981 – 33983)

Digestive – 7 New Codes

• Laparoscopy, Repair of Paraesophageal Hernia (43281 & 43282)
• Laparoscopy, Surgical, Gastric Restrictive Procedure; Longitudinal Gastrectomy (43775)

Urinary – 3 New Codes

• Complex Cystometrogram; with Voiding Pressure Studies (51727 – 51729)

Male Genitourinary – 1 New Code

Female Genitourinary – 1 New Code

Nervous – 10 New Codes

• Removal of Spinal Neurostimulator Electrode
• Revision Including Replacement of Spinal Neurostimulator Electrode
  • CPT Codes 63661 – 63664
• Injection(s), Diagnostic or Therapeutic Agent, Paravertebral Facet Joint
  • CPT Codes 64490 - 64495

Radiology – 14 New Codes

• CT, Colonography (74261 & 74262)
• CT, Heart (Previously Category III Codes)
  • CPT Codes 75565 – 75574
• Myocardial Perfusion Imaging
  • CPT Codes 78451 - 78454
• Pathology & Lab – 15 Codes

Medicine – 10 New Codes

• AMA announced on 9/28/09 that they have created a new code specific to vaccine administration and revised existing code 90663 to include the H1N1 vaccine
  • 90470 – H1N1 Immunization Administration (intramuscular, intranasal) Including Counseling When Performed
  • 90663 – Influenza Virus Vaccine, Pandemic Formulation, H1N1

Category III Codes – 20 New Codes

• Sleep Study – Unattended (0203T – 0204T)
• Audiometry (0208T – 0212T)
• Injections, Diagnostic or Therapeutic Agent, Paravertebral Facet Joint With Ultrasound Guidance (0213T – 0218T)
• Placement of Posterior Intrafacet Implant(s) (0219T – 0222T)

Category II Codes – 21 Codes

• F Codes (Quality Measures)
  • Plan for follow-up care for major depressive disorder, documented (0545F)
  • Seizure type(s) and current seizure frequency, documented (1200F)
  • Etiology of epilepsy or epilepsy syndrome(s) reviewed and documented (1205F)
  • Patient interviewed directly by evaluating clinician on or before date of diagnosis of major depressive disorder (2060F)
  • Body Mass Index (BMI), documented (3008F)
  • Cervical cancer screening results documented and reviewed (3015F)
  • Pulmonary function test performed within 12 months prior to surgery (3038F)
  • ABO and Rh blood typing documented as performed (3293F)
  • Group B Streptococcus screening documented as performed during week 35-37 gestation (3294F)
  • Clinical tumor, node and metastases staging documented and reviewed prior to surgery (Lung/Esop Cx) (3323F)
  • MRI or CT scan ordered, reviewed or requested (3324F)
  • Performance status documented and reviewed within 2 weeks prior to surgery (Lung/Esop Cx) (3328F)
  • EEG ordered, reviewed or requested (3650F)
  • Patient screened for tobacco use AND received tobacco cessation counseling, if identified as a tobacco user (4004F)
  • Antidepressant pharmacotherapy considered and not prescribed (4063F)
  • Duration of general or neuraxial anesthesia 60 minutes or longer, as documented in the anesthesia record (4255F)
  • Duration of general or neuraxial anesthesia less than 60 minutes, as documented in the anesthesia record (4256F)
  • Counseling about epilepsy specific safety issues provided to patient or caregiver (4330F)
  • Counseling for women of childbearing potential with epilepsy (4340F)
  • Consideration of referral for a neurological evaluation of appropriateness for surgical therapy for intractable epilepsy within the past 3 years (5200F)
  • Patient queried and counseled about anti-epileptic drug side effects (6070F)

• 2010 Diagnosis Code Changes
• CMS Enrollment Forms
• Preparing for the RACs
• Office of Inspector General (OIG) Work Plan